ma 1

ABX-MA1 is a humanized IgG2 monoclonal antibody inhibitor targeting MCAM/MUC18. It significantly reduces homotypic aggregation and heterotypic adhesion with HUVEC, as well as the formation of experimental lung metastasis. In A375SM/WM2664 xenograft mouse models, ABX-MA1 effectively suppresses tumor growth, angiogenesis, and MMP-2 expression, indicating potential for melanoma research.

XOMA 129 is a human monoclonal antibody that targets the insulin receptor (INSR). This compound acts as an antagonist to the insulin receptor (IR), effectively inhibiting the decrease of blood glucose levels. XOMA 129 is applicable in the research of hypoglycemia.

Anti-Mouse IL-1R Antibody, an IgG2b subclass inhibitor, targets the mouse IL-1 receptor and is sourced from Armenian hamsters.

Gulgafafusp alfa is a human IgG2κ monoclonal antibody that selectively binds to the glucagon-like peptide 1 receptor (GLP1R) [1].

Urtoxazumab (TMA-15) is a humanized monoclonal antibody that targets Shiga toxin 2 (Stx2) [1].

Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) is an IgG1, κ inhibitor antibody derived from rats, targeting mouse E-Cadherin/CD324.

GMA-161 is a humanized IgG1 antibody targeting Fcγ receptor III (CD16). It holds potential for researching autoimmune diseases. For an isotype control, refer to Human IgG1 kappa, Isotype Control.